Literature DB >> 21190476

Diversity of β-lactamases in Pseudomonas aeruginosa isolates producing metallo-β-lactamase in two Tunisian hospitals.

Sonia Ktari1, Basma Mnif, Abir Znazen, Manel Rekik, Sonda Mezghani, Fouzia Mahjoubi-Rhimi, Adnane Hammami.   

Abstract

This study was conducted to identify the β-lactamase content of 30 metallo-β-lactamase-producing Pseudomonas aeruginosa isolated in 2007 from two Tunisian hospitals and to investigate their genetic relatedness. All these isolates produced VIM-2. bla(PER-1), bla(PSE-1), bla(OXA-2), and bla(OXA-10) were identified in 17, 5, 21, and 1 isolates, respectively. These enzymes were often associated in the same isolate: 26 isolates had at least two β-lactamases. The predominant serotype was O12. Pulsed-field gel electrophoresis revealed genetic diversity among the metallo-β-lactamase-producing P. aeruginosa isolates. This is the first report on the existence of bla(PER-1), bla(PSE-1), bla(OXA-2), and bla(OXA-10) in Tunisia. © Mary Ann Liebert, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190476     DOI: 10.1089/mdr.2010.0104

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  11 in total

1.  Dissemination of a class I integron carrying VIM-2 carbapenemase in Pseudomonas aeruginosa clinical isolates from a hospital intensive care unit in Annaba, Algeria.

Authors:  Meriem Touati; Seydina M Diene; Mazouz Dekhil; Abdelghani Djahoudi; Abdelkarim Racherache; Jean-Marc Rolain
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

Review 2.  The spread of carbapenemase-producing bacteria in Africa: a systematic review.

Authors:  Rendani I Manenzhe; Heather J Zar; Mark P Nicol; Mamadou Kaba
Journal:  J Antimicrob Chemother       Date:  2014-09-26       Impact factor: 5.790

3.  Identification of VIM-2-producing Pseudomonas aeruginosa from Tanzania is associated with sequence types 244 and 640 and the location of blaVIM-2 in a TniC integron.

Authors:  Sabrina Moyo; Bjørg Haldorsen; Said Aboud; Bjørn Blomberg; Samuel Y Maselle; Arnfinn Sundsfjord; Nina Langeland; Ørjan Samuelsen
Journal:  Antimicrob Agents Chemother       Date:  2014-10-20       Impact factor: 5.191

4.  Antimicrobial resistance, virulence factors, and genotypes of Pseudomonas aeruginosa clinical isolates from Gorgan, northern Iran.

Authors:  Fatemeh Nemati Shahri; Ahdieh Izanloo; Mohammad Ali Sheikh Beig Goharrizi; Ailar Jamali; Hanieh Bagheri; Afsaneh Hjimohammadi; Abdollah Ardebili
Journal:  Int Microbiol       Date:  2022-06-14       Impact factor: 3.097

Review 5.  Prevalence of Clinically Isolated Metallo-beta-lactamase-producing Pseudomonas aeruginosa, Coding Genes, and Possible Risk Factors in Iran.

Authors:  Abdolmajid Ghasemian; Kobra Salimian Rizi; Hassan Rajabi Vardanjani; Farshad Nojoomi
Journal:  Iran J Pathol       Date:  2018

Review 6.  Carbapenemase Producing Gram-Negative Bacteria in Tunisia: History of Thirteen Years of Challenge.

Authors:  Olfa Dziri; Raoudha Dziri; Allaaeddin Ali El Salabi; Chedly Chouchani
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

7.  Evaluation of Three Carbapenemase-Phenotypic Detection Methods and Emergence of Diverse VIM and GES Variants among Pseudomonas aeruginosa Isolates in Tunisia.

Authors:  Sana Ferjani; Elaa Maamar; Asma Ferjani; Lamia Kanzari; Ilhem Boutiba Ben Boubaker
Journal:  Antibiotics (Basel)       Date:  2022-06-27

8.  Characterization of antibiotic resistance profiles in Pseudomonas aeruginosa isolates from burn patients.

Authors:  Asma Tchakal-Mesbahi; Merzak Metref; Vijay K Singh; Marianna Almpani; Laurence G Rahme
Journal:  Burns       Date:  2021-03-17       Impact factor: 2.744

9.  Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.

Authors:  Sami Abdellatif; Ahlem Trifi; Foued Daly; Khaoula Mahjoub; Rochdi Nasri; Salah Ben Lakhal
Journal:  Ann Intensive Care       Date:  2016-03-31       Impact factor: 6.925

10.  Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study.

Authors:  Ahlem Trifi; Sami Abdellatif; Cyrine Abdennebi; Foued Daly; Rochdi Nasri; Yosr Touil; Salah Ben Lakhal
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-11-16       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.